Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$17,785,602
in 2 filings, $14.7M under 10b5-1 plans

Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-01-10 Adsett Roger Chief Operating Officer Sale 10b5-1 −3,536 $28.90 $102K 153,810
2024-01-09 Wise John Drayton Chief Commercial Officer Sale −1,861 $28.78 $54K 113,829
2024-01-09 Smith Michael Alexander General Counsel, Senior VP Sale −2,373 $28.76 $68K 86,364
2024-01-09 Schaeffer Orlov S Nicole Chief People Strategy Officer Exercise or conversion 10b5-1 +503 $20.49 $10K 105,652
2024-01-09 Schaeffer Orlov S Nicole Chief People Strategy Officer Sale 10b5-1 −503 $29.56 $15K 105,149
2024-01-09 Schaeffer Orlov S Nicole Chief People Strategy Officer Sale 10b5-1 −3,165 $28.74 $91K 101,984
2024-01-09 Schaeffer Orlov S Nicole Chief People Strategy Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −503 0
2024-01-09 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −4,715 $29.01 $137K 112,810
2024-01-09 Bonstein Sara Chief Financial Officer Sale −4,497 $29.18 $131K 114,051
2024-01-09 Adsett Roger Chief Operating Officer Sale 10b5-1 −3,837 $29.25 $112K 157,346
2024-01-09 Lewis William Chair and CEO Sale 10b5-1 −9,887 $28.72 $284K 363,651
2024-01-08 Lewis William Chair and CEO Exercise or conversion 10b5-1 +24,951 $20.49 $511K 398,489
2024-01-08 Lewis William Chair and CEO Sale 10b5-1 −24,951 $29.11 $726K 373,538
2024-01-08 Lewis William Chair and CEO Exercise or conversion 10b5-1 +20,169 $20.49 $413K 393,707
2024-01-08 Lewis William Chair and CEO Sale 10b5-1 −20,169 $29.88 $603K 373,538
2024-01-08 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 +45,120 $20.49 $925K 0
2024-01-05 Wise John Drayton Chief Commercial Officer Sale 10b5-1 −1,167 $29.32 $34K 115,690
2024-01-05 Smith Michael Alexander General Counsel, Senior VP Sale −627 $29.31 $18K 88,737
2024-01-05 Schaeffer Orlov S Nicole Chief People Strategy Officer Sale −1,457 $29.28 $43K 105,149
2024-01-05 Lewis William Chair and CEO Sale −6,979 $29.26 $204K 373,538

Page 43 of 54 · 1,061 trades